In order to study the mechanism of the effect of heparin on apoptosis in carcinoma cells, the nasopharyngeal carcinoma cell line CNE2 was used to identify the effect of heparin on apoptosis associated with the expression of c-myc, bax, bcl-2 proteins by use of Hoechst 33258 staining, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL), agarose gel electrophoresis, and flow cytometry, as well as Western blot analysis. The results showed that heparin induced apoptosis of CNE2 cells including the morphologic changes such as reduction in the volume, and the nuclear chromatin condensation, as well as the ladder pattern revealed by agarose gel electrophoresis of DNA in a concentration-dependent manner. The number of TUNEL-positive cells was dramatically increased to 33.6 1.2% from 2.8 0.3% by treatment with heparin in different concentrations (10 ~ 40 kU/L). The apoptotic index was increased to 32.5% from 3.5% by detecting SubG1 peaks on flow cytometry. Western blot analysis showed that levels of bcl-2, bax and c-myc were significantly overexpressed by treatment with the increase of heparin concentrations. These results suggest that heparin induces apoptosis of CNE2 cells, which may be regulated by differential expression of apoptosis-related genes.
INTRODUCTION
Heparin is a polysulfated glycosaminoglycan with a high negative charge. Heparin is synthesized in various tissues, especially in the liver, lung, and gut. In addition to its anti-coagulant activity, heparin is known to have anti-hypertensive [1] , anti-inflammatory [2] , and anti-proliferative effects. Besides, heparin inhibits leukocyte rolling and its adhesion to endothelium, its aggregation, degranulation, and the generation of superoxide anion by activating neutrophils [3] [4] [5] . Heparin and heparin sulfate proteoglycan inhibit mitogenesis and migration of cultured mesangial cells [6] , [7] . It also exerts direct actions on the resident glomerular cells.
There are many actions for heparin to exert its effects on the malignant processes. Microthrombin with its fibrin formation, that is resulted from tumors and can in turn arrest tumor cells in capillaries [9] , impede activity of natural killer cell [8] . Heparin prevents the formation of thrombin and neutralizes its activity. Heparin minimizes angiogenesis, that plays an important role in metastasis, via the inhibition of vascular endothelial growth factor and platelet activating factor. It decreases tumor cell adhesion to vascular endothelium as it inhibits actions of selectin and chemokine, and also decreases the replication and activity of some oncogenic viruses [10] . Heparin competitively inhibits tumor cell attachment to heparin sulfate proteoglycans, blocks the oncogenic action of ornithine decarboxylase, and enhances the antineoplastic effect of transforming growth factor [11] . Heparin inhibits activator-protein-1, that is the nuclear target of many oncogenic signal transduction pathways, and potently inhibits carcinogenic casein kinase II [12] .
Although a number of biological properties have been postulated to explain the effects of heparin on the malignant process, it is still unknown whether and how heparin modulates survival of carcinoma cell. In this investigation, we address the potential effects of heparin for inducing the apoptosis of human nasopharyngeal carcinoma CNE2 cells.
MATERIALS AND METHODS

Drugs and reagents
Heparin, RPMI-1640 medium, RNase A, Agarose gel, Hoechst33258, Propidium iodide (PI), Proteinase K, were purchased from Sigma Chemical Co (St. Louis, MO, USA), Cell Death Detection Kit was obtained from Boehringer Mannheim. Antibax, anti-bcl-2, anti-c-myc, and anti-mouse beta-actin antibody, were purchased from Santa Cruz. CNE2 cell line was provided by Cancer Institute, Sun-Yet Sen University of Medical Sciences Guangzhou, China.
Cell culture
CNE2 cell line was cultured in RPMI-1640 medium, containing 10% new bovine serum, penicillin G (100kU/L), and kanamycin (0.1g/L) at 37 o C in a 5% CO 2 air atmosphere.
Hoechst 33258 Staining
Cells were fixed with 4% formaldehyde in phosphate buffered saline (PBS) for 10 min, stained by Hoechst33258 (10mg/L) for 1 h, and then subjected to fluorescence microscopy. After treatment with heparin, the morphologic changes including reduction in the volume and nuclear chromatin condensation were observed.
TUNEL
TUNEL assay was performed using the apoptosis detection system. Cells were fixed with 4% paraformaldehyde in PBS overnight at 4 o C. The samples were washed with PBS and then permeabilized by 0.2% Triton X-100 in PBS for 15 min on ice. 
Flow cytometry
For DNA content analysis, heparin was added to CNE2 cells in mid-logarithmic phase (1 10 9 cells/L). After 48 h, 1 10 6 cells were collected, pelleted, washed with phosphate-buffered saline (PBS), and resuspended in PBS containing 20 mg/L PI and 1 g/L ribonuclease A. 10 6 fixed cells were examined per experimental condition by flow cytometry, and percentage of degraded DNA was determined by the number of cells displaying subdiploid (sub-G 1 ) DNA divided by the total number of cells examined.
Western blot analysis
The cells were lysed in lysis buffer (25 mM Hepes, 1.5% Triton X-100,1% sodium deoxycholate, 0.1 %SDS, 0.5M NaCl, 5mM EDTA, 50 mM NaF, 0.1 mM sodium vanadate, 1mM phenylmethylsulfonyl fluoride (PMSF), and 0.1 g/L leupeptin) (pH7.8) at 4 o C with sonication. The lysates were centrifuged at 15, 000g for 15 min and the concentration of the protein in each lysate was determined with Coomassie brilliant blue G-250. Loading buffer (42 mM Tris-HCl, 10% glycerol, 2.3% SDS, 5% 2-mercaptoethanol and 0.002% bromophenol blue) was then added to each lysate, which was subsequently boiled for 3 min and then electrophoresed on a SDS-polyacrylamidel gel. Proteins were transferred to nitrocellulose and incubated respectively with anti-bcl-2, -bax, and -c-myc antibody, and then with peroxidase-conjugated secondary antibodies. Detection was performed with enhanced chemiluminescence reagent.
Statistical analysis
Data are expressed as means SD. Statistical analysis was performed using Student's test to compare data in different groups. A P value of < 0.05 was used to indicate the statistically significant differences.
RESULTS AND DISCUSSION
Effect of heparin on apoptosis of NPC cell line CNE2
To examine the effect of heparin on the apoptosis, CNE2 cells were pretreated with heparin (10 kU/L 4 0 kU/L). The initiating effect of heparin on the CNE2 cell apoptosis was confirmed by observing Hoechst 33258-stained morphologic changes including reduction in the volume and nuclear chromatin condensation (not shown). Similarly, as shown in Fig 1, the number of TUNEL-positive cells was dramatically increased by the treatment with different concentrations of heparin, and the percentage of apoptosis was increased from 2.8 0.3% to 33.6 1.2%. The pro-apoptosis effect of heparin was further confirmed by the ladder detection assay and flow cytometry. Agarose gel electrophoresis showed DNA ladder formation in exposed CNE2 cells. The DNA ladder was clearly embodied by the treatment with heparin (Fig 2) . Low-concentration heparin (10 kU/L) was found to be sufficient to induce DNA fragmentation. It can be observed obviously that the profiles of DNA histograms were strikingly different from untreated CNE2 cells; the subG 1 peak and apoptotic index were increased from 3.5% to 32.5% (Fig 3) . Heparin has been considered as an anti-mitotic agent for several cell types, especially for vascular smooth muscle cells and glomerular mesangial cells. However, little information is available concerning the effect of heparin on apoptotic processes. It is suggested by some reports that heparin may facilitate apoptosis in human peripheral blood neutrophils and in human lymphoblasts, mononuclear cells [13] .
On the other hand, it is also suggested that heparin inhibits apoptosis in cultured mesangial cells and explanted glomeruli [14] . Nevertheless, the effect of heparin on apoptotic processes has not been clearly defined in carcinoma cells, although well studied in normal cells. In this investigation, we demonstrated a novel potential effect of heparin as an inducer of apoptosis in nasopharyngeal carcinoma (NPC) cell line, CNE2 cells, which showed that heparin induces the apoptosis of CNE2 cells in a dose-dependent manner.
Enhanced expression of c-myc and the ratios of bax/ bcl-2 in CNE2 cells exposed to heparin
Less is known about the molecular mechanisms underlying the pro-apoptotic action of heparin. Pre-vious researches have shown that heparin inhibits a PKC-dependent pathway for cell proliferation by suppressing the expression of c-fos and c-myc protooncogene, as well as IL-11 and GM-CSF mRNAs [15] in murine fibroblasts and vascular smooth muscle cells. Heparin, that was proved to be a potent inhibitor of PKC, interacted with the catalytic domain of PKC. However, the present study, as shown in Fig 4, revealed that heparin increased the expression of bcl-2, bax, and c-myc in cultured human nasopharyngeal carcinoma (NPC) cell line CNE2.
It depends upon the interaction of other signals and related genes as whether or not c-myc in a particular cell type will promote cell proliferation and differentiation or induces apoptosis. The c-myc-mediated apoptosis could be suppressed by cytokines such as platelet-derived growth factor (PDGF), insulin-like growth factor-I (IGF-I), and bcl-2. [16] [17] [18] [19] . The c-myc promoter is characteristic of uniquely showing both RNA polymerase II (pol II) and RNA polymerase III (pol III) activities. Previous studies demonstrated that activating PKC resulted in upregulation of c-myc expression from its pol II promoter. PKC has recently been demonstrated to inhibit transcription from the pol III promoter of human c-myc gene [20] . Our present study showed that heparin, a potent inhibitor of PKC, increased the protein level of c-myc. It is possible that the overexpression of c-myc in heparin-treated CNE2 cells is related to the transcriptional inhibition of c-myc pol III promoter. The c-myc proto-oncogene has two coupled opposing functions: proliferation and apoptosis, that suggests that other gene products may interact with c-myc so that the final output of cells could be determined. A candidate for such a modifying gene is probably bcl-2 [21] [22] [23] . Activated bcl-2 gene could prevent apoptosis induced by c-myc. The bax, another bcl-2 family gene, was observed to increase when c-myc was overexpressed [24] . bcl-2 can form heterodimers with bax and lose its protective effect. When bax is present in excess, cells are susceptible to programmed cell death. Thus it seems that the relative ratios of bax and bcl-2, rather than the absolute values of either genes [25] , determine the fate of a cell. Although we found that both bax and bcl-2 genes are expressed in cultured CNE2 cells, the changes were different in these two genes induced by heparin. The levels of bax protein in cultured CNE2 cells increased along with the increase of he- parin concentrations. In contrast, the expression of bcl-2 showed no apparent changes after treatment with heparin in various concentrations. Therefore, according to the increased bax/bcl-2 ratio, the inhibitory effect of bcl-2 on c-myc-induced apoptosis might have been affected, and excessive expression of bax gene probably stimulated the apoptosis of CNE2 cells.
In conclusion, heparin induces apoptosis in CNE2 cells, which may be probably regulated by increased expression of c-myc and the rates of bax/ bcl-2. These findings suggest that heparin may function as an inducer of apoptosis in carcinoma cells. Further investigation will be required to determine the spectrum of pro-apoptotic potential effects in various carcinoma cells, as well as the molecular mechanisms underlying the pro-apoptotic action of heparin in human nasopharyngeal carcinoma CNE2 cells. 
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